tirzepatide ncbi Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Efficacy and safety of once-weekly

rather, it undergoes non-enzymatic conversion to creatinine, which is then excreted by the kidneys

Other diabetes medications, such as insulin, may need reduction to prevent excessively low blood sugar

reported superior Hgba1c control with tirzepatide 5 mg,10 mg, and 15 mg compared to semaglutide 1 mg at 40 weeks ( 2.01 percentage points, 2.24 percentage points, and 2.30 percentage points with 5 mg, 10 mg, and 15 mg of tirzepatide, and 1.86 percentage semaglutide) [32]

Fact: This is known as spot reduction, and it is a myth

In this trial, the achievement of at least a 5% reduction in body weight from baseline occurred more frequently for patients treated with CONTRAVE 32 mg/360 mg compared with placebo (42% vs 17%

Gastrointestinal changes often appear in week one as well